For example, in Ontario, the Comprehensive Cancer Biomarker Testing Program offers biomarker testing, but the testing is limited to specific testing sites and is only available for certain cancer types and testing indications (e.g., KRAS testing for patients with advanced CRC) [15]. The gene discussed is KRAS; the disease is cancer.